Chronic wounds are a silent epidemic, affecting millions worldwide and often leading to devastating complications like amputations. But what if we could disarm the very bacteria that prevent these wounds from healing? An international team of scientists, spearheaded by NTU Singapore, has uncovered a groundbreaking approach that could revolutionize the treatment of chronic wounds infected by antibiotic-resistant superbugs. And this is the part most people miss: it’s not about killing the bacteria, but neutralizing their harmful weapons.
Globally, chronic wounds pose a significant health burden, with an estimated 18.6 million people developing diabetic foot ulcers annually. Shockingly, up to one in three individuals with diabetes are at risk of experiencing a foot ulcer in their lifetime. These wounds are not only painful but also notoriously difficult to treat, often leading to lower-limb amputations due to persistent infections.
In Singapore, the situation is equally alarming, with over 16,000 cases of chronic wounds reported each year, particularly among older adults and those with diabetes. These wounds, including diabetic foot ulcers, pressure injuries, and venous leg ulcers, are a growing concern for healthcare providers.
Published in Science Advances, this collaborative study between NTU Singapore and the University of Geneva, Switzerland, sheds light on the role of Enterococcus faecalis (E. faecalis), a common bacterium, in hindering wound healing. But here’s where it gets controversial: instead of producing toxins like other bacteria, E. faecalis generates a metabolic byproduct called reactive oxygen species (ROS), specifically hydrogen peroxide, which wreaks havoc on human skin cells.
Led by NTU Associate Professor Guillaume Thibault and University of Geneva’s Professor Kimberly Kline, the team discovered that E. faecalis employs a unique metabolic process called extracellular electron transport (EET) to continuously produce hydrogen peroxide. This highly reactive molecule induces oxidative stress in skin cells, triggering a defense mechanism known as the “unfolded protein response.” While this response is meant to help cells recover from damage, it inadvertently paralyzes them, preventing the migration of skin cells necessary for wound closure.
In a striking experiment, researchers used a genetically modified strain of E. faecalis lacking the EET pathway. These bacteria produced significantly less hydrogen peroxide and were unable to impede wound healing, confirming the central role of this metabolic process in disrupting skin repair.
But here’s the game-changer: instead of relying on antibiotics, which are increasingly ineffective against resistant strains, the team found that treating affected skin cells with catalase—a natural antioxidant enzyme that breaks down hydrogen peroxide—reduced cellular stress and restored the cells’ ability to heal. This approach bypasses the need to kill the bacteria, focusing instead on neutralizing their harmful effects.
“Our findings reveal that the bacteria’s metabolism itself is the weapon, a previously unknown mechanism,” said Assoc Prof Thibault. “By blocking the harmful products it generates, we can restore wound healing without resorting to antibiotics, which often lead to further resistance.”
This study not only establishes a direct link between bacterial metabolism and host cell dysfunction but also opens the door to innovative treatments. The researchers propose that wound dressings infused with antioxidants like catalase could become a cornerstone of future therapies for chronic wounds.
But what do you think? Is this antibiotic-free approach the future of wound care, or are there potential downsides we’re not considering? Share your thoughts in the comments below—let’s spark a conversation about the next frontier in combating superbugs and healing chronic wounds.
